ricardo n dos santos
Experian (United Kingdom)
Nottingham, United Kingdom
Review Editor
Drug Discovery in Bioinformatics
Experian (United Kingdom)
Nottingham, United Kingdom
Review Editor
Drug Discovery in Bioinformatics
University of Tehran
Tehran, Iran
Review Editor
Drug Discovery in Bioinformatics
Stockholm University
Stockholm, Sweden
Review Editor
Drug Discovery in Bioinformatics
London School of Hygiene and Tropical Medicine, University of London
London, United Kingdom
Review Editor
Drug Discovery in Bioinformatics
Institute of Biochemistry and Biophysics, University of Tehran
Tehran, Iran
Review Editor
Drug Discovery in Bioinformatics
Mahapurusha Srimanta Sankaradeva Viswavidyalaya
Nagaon, India
Review Editor
Drug Discovery in Bioinformatics
Technion Israel Institute of Technology
Haifa, Israel
Review Editor
Drug Discovery in Bioinformatics
Washington University in St. Louis
St. Louis, United States
Review Editor
Drug Discovery in Bioinformatics
United States Food and Drug Administration
Silver Spring, United States
Review Editor
Drug Discovery in Bioinformatics
School of Science, College of Science, Engineering and Health, RMIT University
Melbourne, Australia
Review Editor
Drug Discovery in Bioinformatics
Carnegie Mellon University
Pittsburgh, United States
Review Editor
Drug Discovery in Bioinformatics
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Drug Discovery in Bioinformatics
Duke Human Vaccine Institute, School of Medicine, Duke University
Durham, United States
Review Editor
Drug Discovery in Bioinformatics
Izmir Biomedicine and Genome Center, Dokuz Eylul University
Izmir, Türkiye
Review Editor
Drug Discovery in Bioinformatics
Bowie State University
Bowie, United States
Review Editor
Drug Discovery in Bioinformatics
University Hospital and Faculty of Medicine, University of Tübingen
Tübingen, Germany
Review Editor
Drug Discovery in Bioinformatics